Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide

Experts consensus of the Russian Cardiology Society (RSC)

Saved in:

Bibliographic Details
Main Authors:	A. O. Konradi, S. V. Nedogoda, A. O. Nedoshivin, L. G. Ratova, R. A. Libis, G. P. Arutyunov, N. Yu. Borovkova, A. S. Galyavich, Yu. I. Grinshteyn, D. V. Duplyakov, V. V. Kashtalap, Yu. M. Lopatin, N. P. Lyamina, S. V. Malchikova, V. P. Mikhin, G. I. Nechaeva, O. D. Ostroumova, T. M. Ripp, G. A. Chumakova, I. I. Shaposhnik, V. V. Yakusevich
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-04-01
Series:	Российский кардиологический журнал
Subjects:	hypertension fixed-dose combination ramipril indapamide
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3782
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program
by: A. O. Konradi, et al.
Published: (2021-10-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
by: I. E. Chazova, et al.
Published: (2010-08-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
by: A. G. Kuzmin, et al.
Published: (2014-08-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Effectiveness of ACE inhibitor ramipril and its combination with hydrochlorothiazide in patients with arterial hypertension and overweight: CHARISMA Study
by: I. P. Kolos, et al.
Published: (2008-04-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE
by: I. I. Sinitsina, et al.
Published: (2016-01-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
by: A. A. Shadrin, et al.
Published: (2019-01-01)

Ramipril effects on cerebral blood flow and microcirculation in patients with essential arterial hypertension
by: L. I. Markova, et al.
Published: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
by: S. V. Nedogoda
Published: (2016-09-01)

Development and Validation of HPLC Method for Identification of Ramipril in Printed Tablets and Filaments
by: V. V. Tihonova, et al.
Published: (2022-11-01)

Effectiveness of ramipril and amlodipine combination in patients with arterial hypertension, Type 2 diabetes mellitus, and anxiety and depressive disorders
by: Yu. V. Bochkareva, et al.
Published: (2009-08-01)

EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril
by: A. I. Kochetkov, et al.
Published: (2020-07-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
by: O. A. Terenteva, et al.
Published: (2021-12-01)

Study of Lercanidipine Drug Release from Medicine in Combination with Ramipril <i>in vitro</i> and <i>in vivo
by: A. A. Shadrin, et al.
Published: (2019-09-01)

USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01)

Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats
by: Nancy M. Abdel-Kareem, et al.
Published: (2025-07-01)

Ramipril and amlodipine therapy effects on endothelial vasodilatation, metabolic profile, and arterial hypertension course in women with postmenopausal metabolic syndrome
by: A. R. Ishmanova, et al.
Published: (2010-02-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter
by: Ya. V. Zemlyaniy
Published: (2014-04-01)

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01)

Personalized management of hypertensive patients: focus on prognostic biomarkers
by: S. V. Lyamina, et al.
Published: (2022-05-01)

Comparative protective effects of rosuvastatin and ramipril against doxorubicin-induced testicular toxicity in rats: A multimodal evaluation of oxidative stress and reproductive parameters
by: B. Anisha, et al.
Published: (2025-08-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
by: A. O. Konradi, et al.
Published: (2025-02-01)

Layer-by-Layer Engineering of Black Seed Oil Based SNEDDSs (BSO-SNEDDSs): Optimizing Chemical Stability and Bioavailability in Ramipril Formulations
by: Shahba AAW, et al.
Published: (2025-04-01)

Therapeutic and biopharmaceutical assessment of indapamide medications
by: G. V. Ramenskaya, et al.
Published: (1970-01-01)

HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2016-01-01)

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?
by: D. V. Nebieridze, et al.
Published: (2016-01-01)

Single-pill combination of indapamide and perindopril: potential of practical application
by: A. M. Kochergina, et al.
Published: (2024-04-01)

ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

The investigation of kinetics dissolution of prolonged indapamide drugs in biorelevant media
by: E. Yu. Sannikova, et al.
Published: (2013-03-01)

Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy
by: M. N. Mamedov, et al.
Published: (2011-08-01)

STUDY OF PATIENTS ADHERENCE TO TREATMENT IN METABOLIC SYNDROME, WITH THE NOVEL COMBINATION ANTIHYPERTENSION COMPOUND OF RAMIPRIL AND AMLODIPINE BY THE DATA OF OBSERVATIONAL STUDY GRANAT-1
by: S. Yu. Martsevich, et al.
Published: (2017-02-01)